Stromal cell-derived factor 1α stimulates human endometrial carcinoma cell growth through the activation of both extracellular signal-regulated kinase 1/2 and Akt

Gynecologic Oncology

Volumn 103, Issue 3, 2006, Pages 932-937

  Zhao, Dan ^a   Li, Xiao ping ^a   Gao, Min ^a   Zhao, Chao ^a   Wang, Jian liu ^a   Wei, Li hui ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Human endometrial carcinoma cell; Stromal cell derived factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1ALPHA;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINES, CXC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 33751399462     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.05.045     Document Type: Article

References (17)

1. Castoria G., Barone M.V., Domenico M.D., et al. Non-transcriptional action of estradiol and progestin trigger DNA synthesis. EMBO J. 18 (1999) 2500-2510
2. Nagasawa T., Kikutani H., Kishimoto T., et al. Molecular cloning and structure of pre-B-cell stimulating factor. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 2305-2309
3. Schrader A., Lechner O., Templin M., et al. CXCR4/CXCL12 expression and signaling in kidney cancer. Br. J. Cancer 86 (2002) 1250-1256
4. Barbero S., Bonavia R., Bajetto A., et al. Stromal cell-derived factor 1α stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res. 63 (2003) 1969-1974
5. Hall J.M., and Korach K.S. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol. Endocrinol. 179 (2003) 792-803
6. Mizokami Y., Kajiyama H., Shibata K., et al. Stromal cell-derived factor-1α induced cell proliferation and its possible regulation by cd26/dipeptidyl peptidase iv in endometrial adenocarcinoma. Int. J. Cancer 110 (2004) 652-659
7. Bussaglia E., del Río E., Matías-Guiu X., et al. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. Hum. Pathol. 31 (2000) 312-317
8. Yaginuma Y., Yamashita T., Ishiva T., et al. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers. Mol Carcinog 2 (2000) 110-116
9. Muller A., Homey B., Soto H., et al. HEC-1 cells. Hum Cell 15 (2002) 81-95
10. Li X.-p., Zhao D., Gao M., et al. Growth and activation of PI-3K/PKB and Akt by stromal cell-derived factor 1α in endometrial carcinoma cells with expression of suppressor endoprotein PTEN. Chin. Med. J. 119 (2006) 378-383
11. Kang H., Watkins G., Parr C., et al. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res. 7 (2005) 402-410
12. Scotton C.J., Wilson J.L., Milliken D., et al. Epithelial cancer cell migration: a role for chemokine receptors?. Cancer Res. 61 (2001) 4961-4965
13. Bradstock K.F., Makrynikola V., Bianchi A., et al. Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Leukemia 14 (2000) 82-888
14. Philips R.J., Burdick M.D., Lutz M., et al. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am. J. Respir. Crit. Care Med. 167 (2003) 1676-1686
15. Bajetto A., Bonavia R., Barbero S., et al. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 82 (2002) 1311-1329
16. Cantely L.C., and Neel B.C. New insight into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3 kinase/AKT pathway. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4240-4245
17. Zhang Y.-j., Wei L.-h., Li X.-p., et al. Role of suppressor encoprotein PTEN in IGF-1 induced activation of ERK in endometrial carcinoma cells. Chin. J. Cancer 21 (2002) 724-730 [In Chinese]